39962 Federal Register / Vol. 74, No. 152 / Monday, August 10, 2009 / Notices 

a Federal duty to which the information 

is relevant. 

i. To the National Archives and 

Records Administration (NARA) for 

records management purposes. 

j. To appropriate agencies, entities, 

and persons when (1) The Agency 

suspects or has confirmed that the 

security or confidentiality of 

information in the system of records has 

been compromised; (2) the Agency has 

determined that as a result of the 

suspected or confirmed compromise 

there is a risk of harm to economic or 

property interests, identity theft or 

fraud, or harm to the security or 

integrity of this system or other systems 

or programs (whether maintained by 

GSA or another agency or entity) that 

rely upon the compromised 

information; and (3) the disclosure 

made to such agencies, entities, and 

persons is reasonably necessary to assist 

in connection with GSA’s efforts to 

respond to the suspected or confirmed 

compromise and prevent, minimize, or 

remedy such harm. 

POLICIES AND PRACTICES FOR STORING, 

RETRIEVING, ACCESSING, RETAINING, AND

DISPOSING OF RECORDS IN THE SYSTEM: 

STORAGE: 

All records are stored electronically in 

client-server computer format. 

RETRIEVABILITY: 

Records are retrievable with indexing 

values or other unique identifiers such 

as name or Social Security Number. 

SAFEGUARDS: 

System records are safeguarded in 

accordance with the requirements of the 

Privacy Act. Access is limited to 

authorized individuals with 

strengthened passwords, and the 

database is maintained behind a firewall 

that meets strict GSA OCIO security 

requirements. 

RETENTION AND DISPOSAL: 

System records are retained and 

disposed of according to GSA records 

maintenance and disposition schedules 

and the requirements of the National 

Archives and Records Administration. 

SYSTEM MANAGER AND ADDRESS: 

Director, Financial and Payroll 

Services Division, OCFO, GSA (BCE), 

1500 E. Bannister Road, Kansas City, 

Missouri 66085. 

NOTIFICATION PROCEDURE: 

Individuals wishing to inquire if the 

system contains information about them 

should contact the program manager at 

the above address. 

RECORD ACCESS PROCEDURE: 

Individuals wishing to access their 

own records may do so by sending a 

request to the program manager listed 

above. 

CONTESTING RECORD PROCEDURES: 

GSA rules for access to records, and 

for contesting the contents and 

appealing initial determinations are 

provided in 41 CFR part 105–64. 

RECORD SOURCE CATEGORIES: 

The source for the image data in the 

system originates from the individuals 

and vendors who submit the documents 

on their own behalf. In addition, 

documents may come from Federal 

Government Agencies that may include 

Privacy Act information. 

[FR Doc. E9–19102 Filed 8–7–09; 8:45 am] 

BILLING CODE 6820–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB review; Comment 

Request; 24-hour Dietary Recall 

Method Comparison and the National 

Cancer Institute (NCI) Validation and 

Observational Feeding Studies 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Cancer Institute (NCI), the National 

Institutes of Health (NIH), has submitted 

to the Office of Management and Budget 

(OMB) a request to review and approve 

the information collection listed below. 

This proposed information collection 

was previously published in the Federal 

Register on June 3, 2009 (74 FR 26702) 

and allowed 60-days for public 

comment. One public comment was 

received on June 5 requesting a copy of 

the data collection plans. The plans 

were sent to the responder on June 10. 

The purpose of this notice is to allow an 

additional 30 days for public comment. 

The National Institutes of Health may 

not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

Proposed Collection: Title: 24-hour 

Dietary Recall Method Comparison and 

the National Cancer Institute (NCI) 

Validation and Observational Feeding 

Studies. Type of Information Collection 

Request: NEW. Need and Use of 

Information Collection: The objective of 

the two studies is to compare the 

performance of the newly developed 

computerized Automated SelfAdministered 24-Hour Recall (ASA24) 

approach to collecting 24-hour recall 

(24HR) data with the current standard, 

the interviewer-administered 

Automated Multiple Pass Method 

(AMPM). The ultimate goal is to 

determine to what extent the new 

automated instrument can be used 

instead of the more expensive 

interviewer-administered instrument in 

the collection of dietary intake data. 

Frequency of Response: Twice. Affected 

Public: Individuals. Type of 

Respondents: For the 24-hour Dietary 

Recall Method Comparison study, 

approximately 1,200 adult members 

from three health maintenance 

organization plans (in Minnesota, 

California, and Michigan) between ages 

20 and 70 years. For the NCI 

Observational Feeding Study, 

approximately 90 adult residents from 

the Washington, DC metropolitan area 

between ages 20 and 70 years. The 

annual reporting burden is estimated at 

1052 hours (see table below). This 

amounts to an estimated 2105 burden 

hours over the 2-year data collection 

period with a total cost to the 

respondents $37,210. There are no 

Capital costs, Operating costs, and/or 

Maintenance Costs to report. 

Study Questionnaire Number of 

respondents 

Frequency 

of 

response 

Average 

time 

response 

(Minutes) 

Annual hour 

burden 

24HR recall comparison study: 

Information and Consent .......................................................................... 650 1 15/60 162.50 

Screener ................................................................................................... 600 1 3/60 30.00 

Dietary Recall 1 ........................................................................................ 540 1 30/60 270.00 

Dietary Recall 2 ........................................................................................ 486 1 30/60 243.00 

Demographics questionnaire .................................................................... 540 1 8/60 72.00 


rmajette on DSK29S0YB1PROD with NOTICES
Federal Register / Vol. 74, No. 152 / Monday, August 10, 2009 / Notices 39963 

Study Questionnaire Number of 

respondents 

Frequency 

of 

response 

Average 

time 

response 

(Minutes) 

Annual hour 

burden 

Preference survey .................................................................................... 243 1 3/60 12.15 

Subtotal ............................................................................................. ........................ ........................ ........................ 789.65 

NCI validation and observational feeding study: 

Screener ................................................................................................... 100 1 3/60 5.00 

Reminder Telephone Call ......................................................................... 90 1 3/60 4.50 

Eating 3 meals .......................................................................................... 90 1 135/60 202.50 

Dietary Recall ........................................................................................... 80 1 30/60 40.00 

Demographics questionnaire .................................................................... 80 1 8/60 10.67 

Subtotal ............................................................................................. ........................ ........................ ........................ 262.67 

Total ................................................................................................... ........................ ........................ ........................ 1,052.32 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proposed performance of the 

functions of the agency, including 

whether the information may have 

practical utility; (2) The accuracy of the 

estimate of the burden of the proposed 

collection of information including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the 

Attention: NIH Desk Officer, Office of 

Management and Budget, at 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans, contact Frances E. Thompson, 

PhD, Project Officer, National Cancer 

Institute, NIH, EPN 4095A, 6130 

Executive Boulevard MSC 7335, 

Bethesda, Maryland 20892–7335, or call 

non-toll-free number 301–594–4410, or 

FAX your request to 301–435–3710, or 

e-mail your request, including your 

address, to thompsof@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

Dated: July 31, 2009. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. E9–19022 Filed 8–7–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0366] 

Office of Critical Path Programs— 

Critical Path Initiative 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of grant funds for the 

support of Office of Critical Path 

Programs (OCPP). The goal of OCPP is 

to develop an administrative and 

scientific infrastructure to support the 

creation and execution of a series of 

projects under the FDA’s Critical Path 

Initiative. 

DATES: Important dates are as follows: 

1. The application due date is 

September 7, 2009. 

2. The anticipated start date is in 

September 2009. 

3. The opening date is August 10, 

2009. 

4. The expiration date is September 8, 

2009. 

FOR FURTHER INFORMATION AND

ADDITIONAL REQUIREMENTS CONTACT: 

Nancy Stanisic, Office of Critical Path 

Programs (HF–18), rm. 14B45, Food 

and Drug Administration, 5600 

Fishers Lane, Rockville, MD 20857, 

301–827–1660. 

Gladys M. Bohler, Grants 

Management Specialist, Office of 

Acquisitions and Grants Services 

(HFA–500), Food and Drug 

Administration, 5630 Fishers Lane, 

rm. 2105, Rockville, MD 20857, 

301–827–7168. 

For more information on this funding 

opportunity announcement (FOA) and 

to obtain detailed requirements, please 

refer to the full FOA located at http:// 

www.fda.gov/oc/initiatives/criticalpath/ 

. 

SUPPLEMENTARY INFORMATION: 

I. Funding Opportunity Description 

Funding Opportunity Description 

Number: RFA FD–09–019 

Catalog of Federal Domestic Assistance 

Number: 93.103 

A. Background 

The Critical Path Initiative, launched 

by FDA in 2004, has the objective of 

helping modernize the development, 

evaluation, manufacture, and use of 

FDA-regulated products. Through 

nationwide collaboration with other 

Federal, academic, scientific, and 

industry organizations, the initiative 

seeks to develop new tools to facilitate 

innovation in FDA-regulated product 

development. Examples of tools include 

novel biomarkers, laboratory assays, 

genetic tests, and state-of-the art 

information technologies, etc. In this 

initiative, FDA plays the role of a 

facilitator in the creation of partnerships 

and collaborations to support specific 

scientific projects. 

B. Research Objectives 

FDA’s Office of the Commissioner is 

announcing its intent to accept and 

consider a single source application for 

the award of a Cooperative Agreement 

to the Critical Path Institute (C-Path). 

FDA anticipates providing up to $1.5 

million (direct and indirect costs 

combined) during fiscal year (FY) 2009 

to support research and related efforts of 


rmajette on DSK29S0YB1PROD with NOTICES